(Jakarta) The Food and Drug Administration (BPOM) has officially approved the coronavirus vaccine produced by China Kexing Pharmaceutical Co., Ltd., which can be vaccinated by people over 60 years old.
Food and Drug Administration's vaccination spokesperson, Dr. Lucia Lizka Andalusia, told reporters on Sunday (7th) that, indeed, the authorities have promised to provide the elderly with vaccination needs. The Food and Drug Administration wrote to the National Pharmaceutical Information Center (PIONAS) in the annex about Kexing vaccine that two doses of 0.5 ml of the vaccine will be injected intramuscularly within 28 days for elderly people aged 60 or over. .
Therefore, it is expected that if the relevant elderly experience the following health conditions, they should report to the duty officer of the health authority:
-difficulty climbing 10 stairs;
-decreased physical activity (often feeling tired);
-11 diseases, including high blood pressure, high blood sugar, cancer (except for minor skin cancers), chronic tuberculosis, heart attack, congestive heart failure, chest pain, joint pain, asthma, stroke and kidney disease 4 kinds of diseases;
-experienced difficulty in walking about 100 to 200 meters;
-1 significant weight loss within one year.
When asked specifically about the vaccination plan for medical personnel over 60, she replied that this matter is still within the purview of the Ministry of Health. "The timing of vaccination is the responsibility of the Ministry of Health."
Earlier, Siti Nadia Talmic, spokesperson for vaccination implementation of the Ministry of Health, said several days ago that elderly people over 60 years old will become the public. The third period of vaccinations after the service attendant. However, she said that, of course, we still need to wait for the results of the FDA's discussion on the safety that can be obtained, such as whether we can safely use the Coxing vaccine to provide to the elderly over 60 years old?
As of last Saturday (6th), my country's vaccination has already enrolled 770,096 medical personnel, or 49.66% of the initial vaccination target. At present, the Ministry of Health has obtained 137,207 doses of the second vaccine preparation. (MIM)
.
